Read our expansion updates Expansion update Covid update
Sjaak Stevense, MD

Sjaak Stevense, MD

Director of Commercial Productions

Prior to joining BioConnection in 2008, Sjaak worked for over 25 years for several international(bio) pharmaceutical companies at various senior (mainly marketing) positions. During this time he was responsible for revenues, P&L, licensing, strategy, marketing & sales, field force & product management. From 1982 until 1997 he worked for Sandoz Pharma (now Novartis) among others at their HQ in Basel, Switzerland. In the period 1998-2008 he worked for life sciences companies such as DSM Biologics (Director Sales Europe) and Rhein Biotech (Marketing & Sales Director).

Sjaak studied Medicine at the University of Amsterdam. At this University he also worked in parallel until his graduation in the faculties of human anatomy, physiology an kinesiology as a teacher.

After being 10 years active as Director of Business Development at BioConnection (which resulted in an impressive track record with many satisfied clients for clinical trial material productions), Sjaak’s new function within BioConnection as of 2018 is Director of Commercial Productions. In this new assignment his challenge will be to support new clients for long term commercial supply contracts that will be manufactured on the new production line of BioConnection for which Sjaak will act as the prime contact.

The new production line (250L compounding plus a 10 m² freeze drier) will significantly increase the production capacity of BioConnection and will be an important growth factor for the sustained growth of BioConnection. The new production line is anticipated to be ready for GMP productions in H1/ 2021.

Please be invited to browse through our website and discover how BioConnection can support your sterile production needs (either liquid or freeze dried) from a few hundred vials per batch up to over 70,000 per batch.

bioconnection

Covid-19 update BioConnection

BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department is on full strength and we have no shortages of material(s) nor do we foresee them.

For our personnel we are following the guidelines as issued by the Dutch National Institute for Public Health and the Environment, RIVM (www.rivm.nl). This means that people stay at home when they show (early) symptoms connected to Covid-19. Furthermore BioConnection employees work from home as much as possible. We avoid shaking hands and keep distance from each other. We take every precaution as advised to prevent the spread of the Covid-19 virus and will fully comply to the requests as stated and/or enforced by the authorities.

Our expansion project (expansion.bioconnection.eu) is running as planned to start GMP production in Q2 2021. We stay in close contact with our suppliers for the production equipment.

We review for Covid policy changes by the authorities on a daily base and adapt to them. If changes occur, this statement will be updated accordingly so you always have the latest information. In case you have any questions, please do not hesitate to contact us via our general number or website. Current customers of BioConnection, can contact their dedicated program manager. In case you want BioConnection to become a partner in your development or manufacturing, please contact our Business Development department via contact@bioconnection.eu.

The BioConnection Management Team.

You have Successfully Subscribed!